{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:45Z","timestamp":1793374245814,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11262-017-1471-x","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T06:16:55Z","timestamp":1496816215000},"page":"684-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models"],"prefix":"10.1007","volume":"53","author":[{"given":"Nicola","family":"Brunetti-Pierri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1201\/b18002-5","volume-title":"Gene and Cell Therapy: Therapeutic Mechanisms and Strategies","author":"N Brunetti-Pierri","year":"2015","unstructured":"N. Brunetti-Pierri, P. Ng, Helper-dependent adenoviral vectors for gene therapy, Gene and Cell Therapy: Therapeutic Mechanisms and Strategies (CRC Press, Boca Raton, 2015), pp. 47\u201384"},{"key":"1471_CR2","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","volume":"96","author":"N Morral","year":"1999","unstructured":"N. Morral, W. O\u2019Neal, K. Rice, M. Leland, J. Kaplan, P.A. Piedra, H. Zhou, R.J. Parks, R. Velji, E. Aguilar-Cordova, S. Wadsworth, F.L. Graham, S. Kochanek, D.K. Carey, A.L. Beaudet, Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96, 12816\u201312821 (1999)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1471_CR3","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2003-01-0314","volume":"102","author":"A Ehrhardt","year":"2003","unstructured":"A. Ehrhardt, H. Xu, A.M. Dillow, D.A. Bellinger, T.C. Nichols, M.A. Kay, A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia. Blood 102, 2403\u20132411 (2003)","journal-title":"Blood"},{"key":"1471_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/hum.2005.16.811","volume":"16","author":"N Brunetti-Pierri","year":"2005","unstructured":"N. Brunetti-Pierri, T.C. Nichols, S. McCorquodale, E. Merricks, D.J. Palmer, A.L. Beaudet, P. Ng, Sustained phenotypic correction of canine hemophilia B after systemic administration of helper-dependent adenoviral vector. Hum. Gene Ther. 16, 811\u2013820 (2005)","journal-title":"Hum. Gene Ther."},{"key":"1471_CR5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","volume":"101","author":"MK Chuah","year":"2003","unstructured":"M.K. Chuah, G. Schiedner, L. Thorrez, B. Brown, M. Johnston, V. Gillijns, S. Hertel, N. Van Rooijen, D. Lillicrap, D. Collen, T. VandenDriessche, S. Kochanek, Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood 101, 1734\u20131743 (2003)","journal-title":"Blood"},{"key":"1471_CR6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","volume":"103","author":"BD Brown","year":"2004","unstructured":"B.D. Brown, C.X. Shi, S. Powell, D. Hurlbut, F.L. Graham, D. Lillicrap, Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A. Blood 103, 804\u2013810 (2004)","journal-title":"Blood"},{"key":"1471_CR7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1538-7836.2006.01901.x","volume":"4","author":"WM Jr","year":"2006","unstructured":"W.M. Jr, M.P. McCormack, T.K. Seiler, K. Bertin, D.J. Ubhayakar, P. Palmer, T.C. Ng, B.Lee Nichols, Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model. J. Thromb. Haemost. 4, 1218\u20131225 (2006)","journal-title":"J. Thromb. Haemost."},{"key":"1471_CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/gt.2011.86","volume":"19","author":"B Crane","year":"2012","unstructured":"B. Crane, X. Luo, A. Demaster, K.D. Williams, D.M. Kozink, P. Zhang, T.T. Brown, C.R. Pinto, K. Oka, F. Sun, M.W. Jackson, L. Chan, D.D. Koeberl, Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia. Gene Ther. 19, 443\u2013452 (2012)","journal-title":"Gene Ther."},{"issue":"Suppl 2","key":"1471_CR9","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/PL00014320","volume":"158","author":"D Matern","year":"1999","unstructured":"D. Matern, T.E. Starzl, W. Arnaout, J. Barnard, J.S. Bynon, A. Dhawan, J. Emond, E.B. Haagsma, G. Hug, A. Lachaux, G.P. Smit, Y.T. Chen, Liver transplantation for glycogen storage disease types I, III, and IV. Eur. J. Pediatr. 158(Suppl 2), S43\u2013S48 (1999)","journal-title":"Eur. J. Pediatr."},{"key":"1471_CR10","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.02384-08","volume":"83","author":"J Crettaz","year":"2009","unstructured":"J. Crettaz, I. Otano, L. Ochoa-Callejero, A. Benito, A. Paneda, I. Aurrekoetxea, P. Berraondo, J.R. Rodriguez-Madoz, A. Astudillo, F. Kreppel, S. Kochanek, J. Ruiz, S. Menne, J. Prieto, G. Gonzalez-Aseguinolaza, Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12. J. Virol. 83, 2663\u20132674 (2009)","journal-title":"J. Virol."},{"key":"1471_CR11","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1128\/JVI.00645-13","volume":"87","author":"M Fiedler","year":"2013","unstructured":"M. Fiedler, A. Kosinska, A. Schumann, O. Brovko, A. Walker, M. Lu, L. Johrden, A. Mayer, O. Wildner, M. Roggendorf, Prime\/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus. J. Virol. 87, 7708\u20137716 (2013)","journal-title":"J. Virol."},{"key":"1471_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.25667","volume":"56","author":"I Otano","year":"2012","unstructured":"I. Otano, L. Suarez, J. Dotor, M. Gonzalez-Aparicio, J. Crettaz, C. Olague, A. Vales, J.I. Riezu, E. Larrea, F. Borras, A. Benito, R. Hernandez-Alcoceba, S. Menne, J. Prieto, G. Gonzalez-Aseguinolaza, Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B. Hepatology 56, 474\u2013483 (2012)","journal-title":"Hepatology"},{"key":"1471_CR13","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/JVI.01787-10","volume":"85","author":"PJ Ross","year":"2011","unstructured":"P.J. Ross, M.A. Kennedy, C. Christou, M. Risco Quiroz, K.L. Poulin, R.J. Parks, Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression. J. Virol. 85, 3950\u20133958 (2011)","journal-title":"J. Virol."},{"key":"1471_CR14","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1128\/JVI.00796-09","volume":"83","author":"PJ Ross","year":"2009","unstructured":"P.J. Ross, M.A. Kennedy, R.J. Parks, Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression. J. Virol. 83, 8409\u20138417 (2009)","journal-title":"J. Virol."},{"key":"1471_CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/hum.2009.020","volume":"20","author":"L Jager","year":"2009","unstructured":"L. Jager, A. Ehrhardt, Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver. Hum. Gene Ther. 20, 883\u2013896 (2009)","journal-title":"Hum. Gene Ther."},{"key":"1471_CR16","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1128\/JVI.77.13.7689-7695.2003","volume":"77","author":"A Ehrhardt","year":"2003","unstructured":"A. Ehrhardt, H. Xu, M.A. Kay, Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo. J. Virol. 77, 7689\u20137695 (2003)","journal-title":"J. Virol."},{"key":"1471_CR17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/v5061500","volume":"5","author":"CM Wong","year":"2013","unstructured":"C.M. Wong, E.R. McFall, J.K. Burns, R.J. Parks, The role of chromatin in adenoviral vector function. Viruses. 5, 1500\u20131515 (2013)","journal-title":"Viruses."},{"key":"1471_CR18","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/mt.2010.169","volume":"18","author":"MA Hausl","year":"2010","unstructured":"M.A. Hausl, W. Zhang, N. Muther, C. Rauschhuber, H.G. Franck, E.P. Merricks, T.C. Nichols, M.A. Kay, A. Ehrhardt, Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. Mol. Ther. 18, 1896\u20131906 (2010)","journal-title":"Mol. Ther."},{"key":"1471_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","volume":"15","author":"N Brunetti-Pierri","year":"2004","unstructured":"N. Brunetti-Pierri, D.J. Palmer, A.L. Beaudet, K.D. Carey, M. Finegold, P. Ng, Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum. Gene Ther. 15, 35\u201346 (2004)","journal-title":"Hum. Gene Ther."},{"key":"1471_CR20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/hum.2006.17.391","volume":"17","author":"N Brunetti-Pierri","year":"2006","unstructured":"N. Brunetti-Pierri, T. Ng, D.A. Iannitti, D.J. Palmer, A.L. Beaudet, M.J. Finegold, K.D. Carey, W.G. Cioffi, P. Ng, Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates. Hum. Gene Ther. 17, 391\u2013404 (2006)","journal-title":"Hum. Gene Ther."},{"key":"1471_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/hum.2013.071","volume":"24","author":"N Brunetti-Pierri","year":"2013","unstructured":"N. Brunetti-Pierri, T. Ng, D. Iannitti, W. Cioffi, G. Stapleton, M. Law, J. Breinholt, D. Palmer, N. Grove, K. Rice, C. Bauer, M. Finegold, A. Beaudet, C. Mullins, P. Ng, Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors. Hum. Gene Ther. 24, 761\u2013765 (2013)","journal-title":"Hum. Gene Ther."},{"key":"1471_CR22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.mt.6300102","volume":"15","author":"N Brunetti-Pierri","year":"2007","unstructured":"N. Brunetti-Pierri, G.E. Stapleton, D.J. Palmer, Y. Zuo, V.P. Mane, M.J. Finegold, A.L. Beaudet, M.M. Leland, C.E. Mullins, P. Ng, Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol. Ther. 15, 732\u2013740 (2007)","journal-title":"Mol. Ther."},{"key":"1471_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymthe.2005.03.001","volume":"12","author":"N Brunetti-Pierri","year":"2005","unstructured":"N. Brunetti-Pierri, D.J. Palmer, V. Mane, M. Finegold, A.L. Beaudet, P. Ng, Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol. Ther. 12, 99\u2013106 (2005)","journal-title":"Mol. Ther."},{"key":"1471_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/mt.2008.257","volume":"17","author":"N Brunetti-Pierri","year":"2009","unstructured":"N. Brunetti-Pierri, G.E. Stapleton, M. Law, J. Breinholt, D.J. Palmer, Y. Zuo, N.C. Grove, M.J. Finegold, K. Rice, A.L. Beaudet, C.E. Mullins, P. Ng, Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol. Ther. 17, 327\u2013333 (2009)","journal-title":"Mol. Ther."},{"key":"1471_CR25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/mt.2012.143","volume":"20","author":"N Brunetti-Pierri","year":"2012","unstructured":"N. Brunetti-Pierri, A. Liou, P. Patel, D. Palmer, N. Grove, M. Finegold, P. Piccolo, E. Donnachie, K. Rice, A. Beaudet, C. Mullins, P. Ng, Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques. Mol. Ther. 20, 1863\u20131870 (2012)","journal-title":"Mol. Ther."},{"key":"1471_CR26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/gt.2016.53","volume":"23","author":"DP Rastall","year":"2016","unstructured":"D.P. Rastall, S.S. Seregin, Y.A. Aldhamen, L.M. Kaiser, C. Mullins, A. Liou, F. Ing, C. Pereria-Hicks, S. Godbehere-Roosa, D. Palmer, P. Ng, A. Amalfitano, Long-term, high-level hepatic secretion of acid alpha-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus. Gene Ther. 23, 743\u2013752 (2016)","journal-title":"Gene Ther."},{"key":"1471_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/gt.2014.85","volume":"22","author":"K Oka","year":"2015","unstructured":"K. Oka, C.E. Mullins, R.S. Kushwaha, A.M. Leen, L. Chan, Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector. Gene Ther. 22, 87\u201395 (2015)","journal-title":"Gene Ther."},{"key":"1471_CR28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/biomedicines2020132","volume":"2","author":"P Piccolo","year":"2014","unstructured":"P. Piccolo, N. Brunetti-Pierri, Challenges and prospects for helper-dependent adenoviral vector-mediated gene therapy. Biomedicines. 2, 132\u2013148 (2014)","journal-title":"Biomedicines."},{"key":"1471_CR29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","volume":"86","author":"R Khare","year":"2012","unstructured":"R. Khare, V.S. Reddy, G.R. Nemerow, M.A. Barry, Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J. Virol. 86, 2293\u20132301 (2012)","journal-title":"J. Virol."},{"key":"1471_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mt.2010.229","volume":"19","author":"JM Prill","year":"2011","unstructured":"J.M. Prill, S. Espenlaub, U. Samen, T. Engler, E. Schmidt, F. Vetrini, A. Rosewell, N. Grove, D. Palmer, P. Ng, S. Kochanek, F. Kreppel, Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells. Mol. Ther. 19, 83\u201392 (2011)","journal-title":"Mol. Ther."},{"key":"1471_CR31","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/mt.2008.86","volume":"16","author":"SE Hofherr","year":"2008","unstructured":"S.E. Hofherr, E.V. Shashkova, E.A. Weaver, R. Khare, M.A. Barry, Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol. Ther. 16, 1276\u20131282 (2008)","journal-title":"Mol. Ther."},{"key":"1471_CR32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","volume":"11","author":"H Mok","year":"2005","unstructured":"H. Mok, D.J. Palmer, P. Ng, M.A. Barry, Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol. Ther. 11, 66\u201379 (2005)","journal-title":"Mol. Ther."},{"key":"1471_CR33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.gt.3302441","volume":"12","author":"MA Croyle","year":"2005","unstructured":"M.A. Croyle, H.T. Le, K.D. Linse, V. Cerullo, G. Toietta, A. Beaudet, L. Pastore, PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Ther. 12, 579\u2013587 (2005)","journal-title":"Gene Ther."},{"key":"1471_CR34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/gt.2013.38","volume":"20","author":"E Leggiero","year":"2013","unstructured":"E. Leggiero, D. Astone, V. Cerullo, B. Lombardo, C. Mazzaccara, G. Labruna, L. Sacchetti, F. Salvatore, M. Croyle, L. Pastore, PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice. Gene Ther. 20, 1124\u20131130 (2013)","journal-title":"Gene Ther."},{"key":"1471_CR35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/mp100216h","volume":"8","author":"P Wonganan","year":"2010","unstructured":"P. Wonganan, C.C. Clemens, K. Brasky, L. Pastore, M.A. Croyle, Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus. Mol. Pharm. 8, 78\u201392 (2010)","journal-title":"Mol. Pharm."},{"key":"1471_CR36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/gt.2015.64","volume":"22","author":"C Unzu","year":"2015","unstructured":"C. Unzu, I. Melero, S. Hervas-Stubbs, A. Sampedro, U. Mancheno, A. Morales-Kastresana, I. Serrano-Mendioroz, R.E. de Salamanca, A. Benito, A. Fontanellas, Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression. Gene Ther. 22, 856\u2013865 (2015)","journal-title":"Gene Ther."},{"key":"1471_CR37","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jgm.797","volume":"7","author":"DR Koehler","year":"2005","unstructured":"D.R. Koehler, H. Frndova, K. Leung, E. Louca, D. Palmer, P. Ng, C. McKerlie, P. Cox, A.L. Coates, J. Hu, Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med. 7, 1409\u20131420 (2005)","journal-title":"J Gene Med."},{"key":"1471_CR38","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/mtna.2013.55","volume":"2","author":"H Cao","year":"2013","unstructured":"H. Cao, T.N. Machuca, J.C. Yeung, J. Wu, K. Du, C. Duan, K. Hashimoto, V. Linacre, A.L. Coates, K. Leung, J. Wang, H. Yeger, E. Cutz, M. Liu, S. Keshavjee, J. Hu, Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors. Mol Ther Nucleic Acids. 2, e127 (2013)","journal-title":"Mol Ther Nucleic Acids."},{"key":"1471_CR39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","volume":"20","author":"DA Stanley","year":"2014","unstructured":"D.A. Stanley, A.N. Honko, C. Asiedu, J.C. Trefry, A.W. Lau-Kilby, J.C. Johnson, L. Hensley, V. Ammendola, A. Abbate, F. Grazioli, K.E. Foulds, C. Cheng, L. Wang, M.M. Donaldson, S. Colloca, A. Folgori, M. Roederer, G.J. Nabel, J. Mascola, A. Nicosia, R. Cortese, R.A. Koup, N.J. Sullivan, Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat. Med. 20, 1126\u20131129 (2014)","journal-title":"Nat. Med."},{"key":"1471_CR40","doi-asserted-by":"crossref","first-page":"e5059","DOI":"10.1371\/journal.pone.0005059","volume":"4","author":"EA Weaver","year":"2009","unstructured":"E.A. Weaver, P.N. Nehete, S.S. Buchl, J.S. Senac, D. Palmer, P. Ng, K.J. Sastry, M.A. Barry, Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. PLoS ONE 4, e5059 (2009)","journal-title":"PLoS ONE"},{"key":"1471_CR41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/v1030920","volume":"1","author":"EA Weaver","year":"2009","unstructured":"E.A. Weaver, P.N. Nehete, B.P. Nehete, S.J. Buchl, D. Palmer, D.C. Montefiori, P. Ng, K.J. Sastry, M.A. Barry, Protection against mucosal SHIV challenge by peptide and helper-dependent adenovirus vaccines. Viruses. 1, 920 (2009)","journal-title":"Viruses."}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11262-017-1471-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-017-1471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-017-1471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T14:07:54Z","timestamp":1569420474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11262-017-1471-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1007\/s11262-017-1471-x","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}